These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11114737)

  • 41. Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression.
    Werner H
    Mol Cell Endocrinol; 1998 Jun; 141(1-2):1-5. PubMed ID: 9723878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IGF-IR in neuroprotection and brain tumors.
    Gualco E; Wang JY; Del Valle L; Urbanska K; Peruzzi F; Khalili K; Amini S; Reiss K
    Front Biosci (Landmark Ed); 2009 Jan; 14(1):352-75. PubMed ID: 19273072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of the IGF-I receptor in apoptosis.
    Baserga R; Resnicoff M; D'Ambrosio C; Valentinis B
    Vitam Horm; 1997; 53():65-98. PubMed ID: 9197178
    [No Abstract]   [Full Text] [Related]  

  • 44. The IGF-I receptor and cancer.
    Baserga R; Resnicoff M; Dews M
    Endocrine; 1997 Aug; 7(1):99-102. PubMed ID: 9449042
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of the tyrosine kinase domain of the insulin-like growth factor-I receptor in intracellular signaling, cellular proliferation, and tumorigenesis.
    Hernández-Sánchez C; Blakesley V; Kalebic T; Helman L; LeRoith D
    J Biol Chem; 1995 Dec; 270(49):29176-81. PubMed ID: 7493944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autophosphorylation of the insulin-like growth factor I receptor cytoplasmic domain.
    Lopaczynski W; Terry C; Nissley P
    Biochem Biophys Res Commun; 2000 Dec; 279(3):955-60. PubMed ID: 11162456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in the sites of phosphorylation of the insulin receptor in vivo and in vitro.
    White MF; Takayama S; Kahn CR
    J Biol Chem; 1985 Aug; 260(16):9470-8. PubMed ID: 3848433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathway.
    Sarfstein R; Bruchim I; Fishman A; Werner H
    PLoS One; 2011; 6(9):e24468. PubMed ID: 21931726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IGF-1R targeting in cancer - does sub-cellular localization matter?
    Soni UK; Jenny L; Hegde RS
    J Exp Clin Cancer Res; 2023 Oct; 42(1):273. PubMed ID: 37858153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycan Modulation of Insulin-like Growth Factor-1 Receptor.
    Boothello RS; Sankaranarayanan NV; Sistla JC; Nagarajan B; Sharon C; Chittum JE; Niyaz RY; Roy S; Nandi A; O'Hara CP; Gangji RN; Afosah DK; Ongolu R; Patel BB; Desai UR
    Angew Chem Int Ed Engl; 2022 Dec; 61(49):e202211320. PubMed ID: 36205924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer.
    Msheik ZS; Nassar FJ; Chamandi G; Itani AR; Gadaleta E; Chalala C; Alwan N; Nasr RR
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression.
    Yaron-Saminsky D; Nagaraj K; Sarfstein R; Laron Z; Pasmanik-Chor M; Werner H
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [miR-144-3p Inhibits the Invasion and Metastasis of Lung Adenocarcinoma Cells 
by Targeting IRS1].
    Bai J; Hu Y; Chen X; Chen L; Zhang L; Yin C; Li H
    Zhongguo Fei Ai Za Zhi; 2021 May; 24(5):323-330. PubMed ID: 34034455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis.
    Dong S; Wang Z; Shen K; Chen X
    Front Oncol; 2021; 11():629666. PubMed ID: 33842335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer.
    Buraschi S; Morcavallo A; Neill T; Stefanello M; Palladino C; Xu SQ; Belfiore A; Iozzo RV; Morrione A
    Matrix Biol Plus; 2020 May; 6-7():100022. PubMed ID: 33543020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade.
    Ferrere G; Tidjani Alou M; Liu P; Goubet AG; Fidelle M; Kepp O; Durand S; Iebba V; Fluckiger A; Daillère R; Thelemaque C; Grajeda-Iglesias C; Alves Costa Silva C; Aprahamian F; Lefevre D; Zhao L; Ryffel B; Colomba E; Arnedos M; Drubay D; Rauber C; Raoult D; Asnicar F; Spector T; Segata N; Derosa L; Kroemer G; Zitvogel L
    JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33320838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation.
    Werner H; Sarfstein R; Nagaraj K; Laron Z
    Cells; 2020 Nov; 9(11):. PubMed ID: 33182502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.
    Sarfstein R; Yeheskel A; Sinai-Livne T; Pasmanik-Chor M; Werner H
    Front Endocrinol (Lausanne); 2020; 11():435. PubMed ID: 32733384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy.
    Wang H; Shang Y; Chen X; Wang Z; Zhu D; Liu Y; Zhang C; Chen P; Wu J; Wu L; Kong D; Yang Z; Li Z; Chen X
    Int J Nanomedicine; 2020; 15():4311-4324. PubMed ID: 32606679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patients.
    Sinai-Livne T; Pasmanik-Chor M; Cohen Z; Tsarfaty I; Werner H; Berger R
    Oncotarget; 2020 Apr; 11(17):1515-1530. PubMed ID: 32391121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.